2021
Design and implementation of a prospective cohort study of persons living with and without HIV infection who are initiating medication treatment for opioid use disorder
Biondi BE, Mohanty S, Wyk BV, Montgomery RR, Shaw AC, Springer SA. Design and implementation of a prospective cohort study of persons living with and without HIV infection who are initiating medication treatment for opioid use disorder. Contemporary Clinical Trials Communications 2021, 21: 100704. PMID: 33490708, PMCID: PMC7807244, DOI: 10.1016/j.conctc.2021.100704.Peer-Reviewed Original ResearchOpioid use disorderProspective cohort studyHIV infectionCohort studyMedication treatmentUse disordersDSM-5 opioid-use disordersLongitudinal studyBiological effectsHIV continuumMonth 6Immune responseDifferential biological effectsMOUDHIVSystems biology approachInfectionTreatmentDSM-5DisordersPersonsBiology approachMedicationsBuprenorphineMethadoneChapter 10 Inpatient opioid use disorder treatment for the infectious disease physician
Seval N, Eaton E, Springer S. Chapter 10 Inpatient opioid use disorder treatment for the infectious disease physician. 2021, 189-221. DOI: 10.1016/b978-0-323-68328-9.00010-2.Peer-Reviewed Original ResearchOpioid use disorderInfectious disease physiciansDisease physiciansOpioid use disorder treatmentInitiation of medicationOpioid-related conditionsUse disorder treatmentEvidence-based treatmentsPatient-centered conceptsID consultationTreatment interruptionAcute painUse disordersOUD managementDisorder treatmentInfectionTreatmentPhysiciansCareMedicationsPainBuprenorphineNaltrexoneMethadoneDiagnosis
2020
Preventing HIV outbreaks among people who inject drugs in the United States: plus ça change, plus ça même chose.
Strathdee SA, Kuo I, El-Bassel N, Hodder S, Smith LR, Springer SA. Preventing HIV outbreaks among people who inject drugs in the United States: plus ça change, plus ça même chose. AIDS 2020, 34: 1997-2005. PMID: 32826391, PMCID: PMC7606503, DOI: 10.1097/qad.0000000000002673.Peer-Reviewed Original ResearchConceptsHIV outbreakRecent HIV outbreaksEpidemiology of HIVEvidence-based interventionsOpioid disordersHIV infectionTreatment cascadeEvidence-based responsesHIV epidemicOpioid epidemicHIV preventionPrescription opiatesHIVPWIDSynthetic opioidsDrugsPublic healthInfectionPreventionHigher proportionUnited StatesEpidemicOutbreakEditorial reviewRelentless cycle
2019
Beyond Antibiotics: A Practical Guide for the Infectious Disease Physician to Treat Opioid Use Disorder in the Setting of Associated Infectious Diseases
Seval N, Eaton E, Springer SA. Beyond Antibiotics: A Practical Guide for the Infectious Disease Physician to Treat Opioid Use Disorder in the Setting of Associated Infectious Diseases. Open Forum Infectious Diseases 2019, 7: ofz539. PMID: 31993454, PMCID: PMC6979000, DOI: 10.1093/ofid/ofz539.Peer-Reviewed Original ResearchOpioid use disorderInfectious disease physiciansDisease physiciansUse disordersAssociated infectious diseasesInjection-related infectionsOpioid-related conditionsPatient-centered careUS opioid crisisEvidence-based managementID consultationAcute painHospital dischargeAntimicrobial regimensHospital admissionMedical contactOUD treatmentCommon causeUS FoodDrug AdministrationOpioid crisisInfectious diseasesUnplanned dischargePatientsInfectionInfectious Complications of Addiction: A Call for a New Subspecialty Within Infectious Diseases
Serota DP, Barocas JA, Springer SA. Infectious Complications of Addiction: A Call for a New Subspecialty Within Infectious Diseases. Clinical Infectious Diseases 2019, 70: 968-972. PMID: 31420651, PMCID: PMC7319263, DOI: 10.1093/cid/ciz804.Peer-Reviewed Original ResearchConceptsSubstance use disordersID physiciansHepatitis C virus infectionInfectious diseasesC virus infectionInfectious disease physiciansHuman immunodeficiency virusManagement of addictionComplex biopsychosocial factorsScope of practiceAddiction physiciansInfectious complicationsDisease physiciansImmunodeficiency virusInfectious consequencesVirus infectionClinical careUse disordersBiopsychosocial factorsHealth AdministrationInfectionSuccessful managementPhysiciansNew subspecialtyPotential role
2016
Erratum to “Correlates of retention on extended-release naltrexone among persons living with HIV infection transitioning to the community from the criminal justice system” [Drug Alcohol Depend. 157 (2015) 158–165]
Springer S, Brown S, Di Paola A. Erratum to “Correlates of retention on extended-release naltrexone among persons living with HIV infection transitioning to the community from the criminal justice system” [Drug Alcohol Depend. 157 (2015) 158–165]. Drug And Alcohol Dependence 2016, 161: 372. PMID: 28463553, PMCID: PMC4871258, DOI: 10.1016/j.drugalcdep.2016.02.009.Peer-Reviewed Original Research
2015
The Impact of Implementing a Test, Treat and Retain HIV Prevention Strategy in Atlanta among Black Men Who Have Sex with Men with a History of Incarceration: A Mathematical Model
Lima VD, Graf I, Beckwith CG, Springer S, Altice FL, Coombs D, Kim B, Messina L, Montaner JS, Spaulding A. The Impact of Implementing a Test, Treat and Retain HIV Prevention Strategy in Atlanta among Black Men Who Have Sex with Men with a History of Incarceration: A Mathematical Model. PLOS ONE 2015, 10: e0123482. PMID: 25905725, PMCID: PMC4408043, DOI: 10.1371/journal.pone.0123482.Peer-Reviewed Original ResearchConceptsHIV prevalenceNew infectionsCondom useSexual risk behavior changePrevalence of HIVHIV prevention strategiesCumulative numberRisk behavior changeHistory of incarcerationBlack menHIV incidenceHIV transmissionHIV epidemicPrevention strategiesPrevalenceInfectionMortalityMenPrison releaseBehavior changeStatus quo scenarioSexUnited StatesYearsSetting
2003
Human Immunodeficiency Virus Infection with Human Granulocytic Ehrlichiosis Complicated by Symptomatic Lactic Acidosis
Springer SA, Altice FL. Human Immunodeficiency Virus Infection with Human Granulocytic Ehrlichiosis Complicated by Symptomatic Lactic Acidosis. Clinical Infectious Diseases 2003, 36: e162-e164. PMID: 12802782, DOI: 10.1086/374930.Peer-Reviewed Original ResearchConceptsHuman granulocytic ehrlichiosisSymptomatic hyperlactatemiaLactic acidosisNormal serum lactate levelsHuman immunodeficiency virus (HIV) infectionNucleoside reverse transcriptase inhibitorSymptomatic lactic acidosisImmunodeficiency virus infectionSerum lactate levelsHuman immunodeficiency virusReverse transcriptase inhibitorAcute coinfectionAntiretroviral therapyHIV infectionHepatic insultImmunodeficiency virusAppropriate treatmentVirus infectionLactate levelsFirst presentationGranulocytic ehrlichiosisPatientsHyperlactatemiaAcidosisInfection